生命科学资讯

Lilly to pay $1.2B for Ventyx and its NLRP3 drugs

Immuneering’s pancreatic cancer pill continues to beat standard care, updated first line data show

Lux Capital raises $1.5B for its ninth fund

Pulmocide calls curtains on phase 3 antifungal trial over low response, higher mortality rate

Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication

Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT - PR Newswire

Thermo Fisher Scientific Builds Hub to Support Local Life Sciences Companies - PHILADELPHIA.Today

10x Genomics (TXG) Sees Target Price Increase in Latest Analyst Rating | TXG Stock News - GuruFocus

Thermo Fisher launches obesity registry to track real-world treatment outcomes - drugdiscoverytrends.com

FDA in 2025 holds fewest number of adcomms since the pandemic

10x Genomics price target raised to $18 from $15 at TD Cowen - TipRanks

Post-Hoc Live Jan. 8: Fewer drugs, more chaos — a year under the new FDA

Appointments and advancements for Jan. 7, 2026

Financings for Jan. 7, 2026

In the clinic for Jan. 7, 2026

Other news to note for Jan. 7, 2026

Regulatory actions for Jan. 7, 2026

Strategy To YieldBoost Thermo Fisher Scientific To 3.1% Using Options - Nasdaq

GSK, Ionis claim study success for RNA-based hepatitis B drug

Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Yahoo Finance